Logo image of RDC.DE

REDCARE PHARMACY NV (RDC.DE) Stock Fundamental Analysis

Europe - FRA:RDC - NL0012044747 - Common Stock

87.925 EUR
+9.77 (+12.51%)
Last: 10/6/2025, 5:29:59 PM
Fundamental Rating

3

Taking everything into account, RDC scores 3 out of 10 in our fundamental rating. RDC was compared to 21 industry peers in the Consumer Staples Distribution & Retail industry. While RDC seems to be doing ok healthwise, there are quite some concerns on its profitability. RDC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year RDC has reported negative net income.
In the past year RDC had a positive cash flow from operations.
In the past 5 years RDC always reported negative net income.
RDC had a positive operating cash flow in 4 of the past 5 years.
RDC.DE Yearly Net Income VS EBIT VS OCF VS FCFRDC.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

With a Return On Assets value of -2.81%, RDC is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
RDC has a worse Return On Equity (-6.85%) than 80.95% of its industry peers.
Industry RankSector Rank
ROA -2.81%
ROE -6.85%
ROIC N/A
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
RDC.DE Yearly ROA, ROE, ROICRDC.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

RDC's Gross Margin of 23.16% is in line compared to the rest of the industry. RDC outperforms 47.62% of its industry peers.
RDC's Gross Margin has improved in the last couple of years.
RDC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
RDC.DE Yearly Profit, Operating, Gross MarginsRDC.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

5

2. Health

2.1 Basic Checks

RDC does not have a ROIC to compare to the WACC, probably because it is not profitable.
RDC has less shares outstanding than it did 1 year ago.
The number of shares outstanding for RDC has been increased compared to 5 years ago.
Compared to 1 year ago, RDC has a worse debt to assets ratio.
RDC.DE Yearly Shares OutstandingRDC.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
RDC.DE Yearly Total Debt VS Total AssetsRDC.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.27 indicates that RDC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.27, RDC is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
RDC has a Debt/Equity ratio of 0.61. This is a neutral value indicating RDC is somewhat dependend on debt financing.
RDC has a Debt to Equity ratio of 0.61. This is in the better half of the industry: RDC outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z 3.27
ROIC/WACCN/A
WACC6.92%
RDC.DE Yearly LT Debt VS Equity VS FCFRDC.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

RDC has a Current Ratio of 1.71. This is a normal value and indicates that RDC is financially healthy and should not expect problems in meeting its short term obligations.
RDC has a Current ratio of 1.71. This is amongst the best in the industry. RDC outperforms 90.48% of its industry peers.
RDC has a Quick Ratio of 1.29. This is a normal value and indicates that RDC is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.29, RDC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.29
RDC.DE Yearly Current Assets VS Current LiabilitesRDC.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

RDC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -201.31%.
Looking at the last year, RDC shows a very strong growth in Revenue. The Revenue has grown by 25.78%.
Measured over the past years, RDC shows a very strong growth in Revenue. The Revenue has been growing by 27.59% on average per year.
EPS 1Y (TTM)-201.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%319.05%
Revenue 1Y (TTM)25.78%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%26.49%

3.2 Future

The Earnings Per Share is expected to grow by 52.47% on average over the next years. This is a very strong growth
RDC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.66% yearly.
EPS Next Y49.41%
EPS Next 2Y55.83%
EPS Next 3Y51.95%
EPS Next 5Y52.47%
Revenue Next Year25.61%
Revenue Next 2Y22.72%
Revenue Next 3Y21.15%
Revenue Next 5Y18.66%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RDC.DE Yearly Revenue VS EstimatesRDC.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
RDC.DE Yearly EPS VS EstimatesRDC.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 5 10

1

4. Valuation

4.1 Price/Earnings Ratio

RDC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 106.57, RDC can be considered very expensive at the moment.
RDC's Price/Forward Earnings ratio is rather expensive when compared to the industry. RDC is more expensive than 85.71% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, RDC is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 106.57
RDC.DE Price Earnings VS Forward Price EarningsRDC.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RDC is valued expensively inside the industry as 80.95% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 46.69
RDC.DE Per share dataRDC.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates RDC does not grow enough to justify the current Price/Earnings ratio.
RDC's earnings are expected to grow with 51.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.83%
EPS Next 3Y51.95%

0

5. Dividend

5.1 Amount

RDC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

REDCARE PHARMACY NV

FRA:RDC (10/6/2025, 5:29:59 PM)

87.925

+9.77 (+12.51%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-28 2025-10-28
Inst Owners48.6%
Inst Owner ChangeN/A
Ins Owners7.4%
Ins Owner ChangeN/A
Market Cap1.79B
Analysts78.57
Price Target157.08 (78.65%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)170.32%
Min EPS beat(2)26.81%
Max EPS beat(2)313.82%
EPS beat(4)3
Avg EPS beat(4)86.3%
Min EPS beat(4)-42.68%
Max EPS beat(4)313.82%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.95%
Min Revenue beat(2)-1.13%
Max Revenue beat(2)-0.77%
Revenue beat(4)0
Avg Revenue beat(4)-1.35%
Min Revenue beat(4)-2.24%
Max Revenue beat(4)-0.77%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.84%
PT rev (3m)-6.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.84%
EPS NY rev (3m)11.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 106.57
P/S 0.67
P/FCF N/A
P/OCF 40.82
P/B 3.52
P/tB 17.19
EV/EBITDA 46.69
EPS(TTM)-1.74
EYN/A
EPS(NY)0.83
Fwd EY0.94%
FCF(TTM)-1.75
FCFYN/A
OCF(TTM)2.15
OCFY2.45%
SpS131.57
BVpS25.01
TBVpS5.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.81%
ROE -6.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.16%
FCFM N/A
ROA(3y)-5.45%
ROA(5y)-5.79%
ROE(3y)-11.19%
ROE(5y)-11.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y3.23%
F-Score4
Asset Turnover2.15
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Debt/EBITDA 10
Cap/Depr 115.11%
Cap/Sales 2.96%
Interest Coverage N/A
Cash Conversion 142.36%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.29
Altman-Z 3.27
F-Score4
WACC6.92%
ROIC/WACCN/A
Cap/Depr(3y)87.99%
Cap/Depr(5y)151.24%
Cap/Sales(3y)2.78%
Cap/Sales(5y)3.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-201.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%319.05%
EPS Next Y49.41%
EPS Next 2Y55.83%
EPS Next 3Y51.95%
EPS Next 5Y52.47%
Revenue 1Y (TTM)25.78%
Revenue growth 3Y30.76%
Revenue growth 5Y27.59%
Sales Q2Q%26.49%
Revenue Next Year25.61%
Revenue Next 2Y22.72%
Revenue Next 3Y21.15%
Revenue Next 5Y18.66%
EBIT growth 1Y-216.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year303.27%
EBIT Next 3Y97.51%
EBIT Next 5Y68.49%
FCF growth 1Y-179.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.08%
OCF growth 3Y23.87%
OCF growth 5YN/A